Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aligos Therapeutics Inc ALGS

Healthcare Biotechnology
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases. The Company discovers and develops therapeutics for metabolic dysfunction associated steatohepatitis (MASH) and viruses with high unmet medical need, such as chronic hepatitis B (CHB) and coronaviruses. Its advanced drug... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ALGS)

Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024

GlobeNewswire 5 days ago

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

GlobeNewswire November 6, 2024

Aligos Therapeutics to Announce 3rd Quarter 2024 Financial Results on November 6, 2024

GlobeNewswire October 30, 2024

Aligos Therapeutics Announces U.S. FDA Clearance of IND Application for ALG-000184

GlobeNewswire October 22, 2024

Aligos Therapeutics Announces Acceptance of Abstracts on Incremental Data from ALG-000184 in CHB Subjects and Late-Breaker Oral Presentation of Data from the Phase 2a HERALD Study of ALG-055009 in MASH Subjects at The Liver Meeting (TLM) 2024

GlobeNewswire October 15, 2024

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 11, 2024

Aligos Therapeutics Appoints David Perry as Vice President of Business Development

GlobeNewswire October 1, 2024

Aligos Therapeutics to Present at Investor Conferences in October

GlobeNewswire September 30, 2024

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

GlobeNewswire September 24, 2024
View More News ››

Opinion & Analysis (NDAQ:ALGS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ALGS)

Aligos Therapeutics, Inc. (NASDAQ:ALGS): A Promising Biotech

http://beyondspx.com/2024/07/31/aligos-therapeutics-inc-nasdaqalgs-a-promising-biotech-tackling-unmet-needs-in-liver-diseases-and-viral...
MikeTester - August 2, 2024

Aligos Therapeutics to Host KOL Event to Discuss the Positiv

NEWS: $ALGS Aligos Therapeutics to Host KOL Event to Discuss the Positive Phase 1b Data from ALG-000184 for the Treatment of CHB...
whytestocks - July 10, 2024

5 Things to Know About Aligos Therapeutics!

$ALGS Aligos Therapeutics, Inc. (NASDAQ: ALGS), a clinical-stage biotechnology company, has discontinued development of ALG-020572,...
AviseAnalytics - March 28, 2022
View more Bullboard ››

Majestic Gold Corp.

Majestic Gold Corp.

Majestic Gold Corp. is engaged in mineral resource exploration, development and extraction. It operates the Songjiagou open ...
View More »